Michael E Engel MD MD, PhD, FAAP
Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology
Assistant Professor of Pediatrics Director, Pediatric Hematology/Oncology Fellowship University of Utah School of Medicine Primary Children's Hospital Adjunct Assistant Professor Oncological Sciences Huntsman Cancer Institute
Join to View Full Profile
1204 West Main StreetCharlottesville, VA 22908
Phone+1 434-243-5500
Fax+1 434-982-3816
Dr. Engel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Pediatric Hematology/Oncology, 2003 - 2006- Vanderbilt University Medical CenterResidency, Pediatrics, 2001 - 2003
Vanderbilt University School of MedicineClass of 2001
Certifications & Licensure
VA State Medical License 2018 - 2026
UT State Medical License 2010 - 2020
TN State Medical License 2006 - 2011
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Young Investigator Award Alex's Lemonade Stand Research Foundation
- Medical Scientist Training Program National Institutes of Health
- Boerth Award in Pediatric Medicine Vanderbilt University
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsThe scaffolding function of LSD1/KDM1A reinforces a negative feedback loop to repress stem cell gene expression during primitive hematopoiesis.Mattie J Casey, Alexandra M Call, Annika V Thorpe, Cicely A Jette, Michael E Engel
Iscience. 2023-01-20 - 6 citationsGFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia.Wenxiang Sun, Jingtao Guo, David McClellan, Alexandra Poeschla, Diana Bareyan
Molecular Cancer Research. 2022-04-01 - 9 citationsAssociation of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia.David Spencer Mangum, Julia Meyer, Clinton C. Mason, Soheil Shams, Luke Maese
JAMA Oncology. 2021-10-01
Press Mentions
- Back-to-School Guide for High-Risk Kids: COVID Delta EditionAugust 31st, 2021
Professional Memberships
- Fellow
- Member
- American Society of Pediatric Hematology/OncologyMember
- Children's Oncology GroupMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
